News and Trends 2 Mar 2023
Antiverse identifies therapeutic antibodies targeting GPCRs
Antiverse Ltd has announced the successful identification of functional antibody clusters targeting two G-protein-coupled receptors (GPCRs), both displaying versatile binding profiles and nanomolar affinity. Antiverse, which was featured as one…